Photo taken from Gabriela Kramer-Marek/LinkedIn
Sep 19, 2023, 20:03
Gabriela Kramer-Marek: I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
Gabriela Kramer-Marek, Associate Professor, Reader in Molecular Imaging at The Institute of Cancer Research, London, shared on LinkedIn:
“EANM 2024, Vienna.
I have just presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
I am really happy we did it and NIO Gliwice, Poland and ICR, London UK ”
Source: Gabriela Kramer-Marek/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19
Dec 21, 2024, 19:18
Dec 21, 2024, 18:59
Dec 21, 2024, 18:57
Dec 21, 2024, 18:54